Last CNY46.83 CNY
Change Today -0.60 / -1.27%
Volume 260.8K
300142 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 11:20 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

walvax biotechnology co-a (300142) Snapshot

Open
CNY47.41
Previous Close
CNY47.43
Day High
CNY47.41
Day Low
CNY46.70
52 Week High
02/25/14 - CNY57.13
52 Week Low
06/25/13 - CNY33.69
Market Cap
8.4B
Average Volume 10 Days
531.8K
EPS TTM
CNY0.26
Shares Outstanding
180.0M
EX-Date
--
P/E TM
180.1x
Dividend
CNY0.05
Dividend Yield
0.53%
Current Stock Chart for WALVAX BIOTECHNOLOGY CO-A (300142)

Related News

No related news articles were found.

walvax biotechnology co-a (300142) Related Businessweek News

No Related Businessweek News Found

walvax biotechnology co-a (300142) Details

Walvax Biotechnology Co., Ltd., a biological pharmaceutical company, engages in the research and development, production and sale of bio-medicine products in China and internationally. It offers bio-medicine, such as vaccines and blood products. The company’s products include Haemophilus influenzae type b conjugate vaccine for infants from the age of 2 months to 5 years to induce immunization against infectious diseases, such as meningitis, pneumonia, septicemia, cellulitis, arthritis, and epiglottitis; and Group A, C Meningococcal Polysaccharide conjugate vaccine for infants from the age of 3 months to 5 years preventing diseases, such as cerebrospinal meningitis and septicemia. Walvax Biotechnology Co., Ltd. was founded in 2001 and is headquartered in Kunming, China.

Founded in 2001

walvax biotechnology co-a (300142) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

walvax biotechnology co-a (300142) Key Developments

Walvax Biotechnology Co.,Ltd to Report Fiscal Year 2013 Results on Apr 16, 2014

Walvax Biotechnology Co.,Ltd announced that they will report fiscal year 2013 results on Apr 16, 2014

Walvax Biotechnology Co.,Ltd, Special/Extraordinary Shareholders Meeting, Jan 03, 2014

Walvax Biotechnology Co.,Ltd, Special/Extraordinary Shareholders Meeting, Jan 03, 2014., at 10:00 China Standard Time. Agenda: To consider acquisition of 51% equity in a company held by another company; and to consider acquisition of 12.576% equity in the above company held by a second company.

Walvax Biotechnology Co.,Ltd to Report Q3, 2013 Results on Oct 26, 2013

Walvax Biotechnology Co.,Ltd announced that they will report Q3, 2013 results on Oct 26, 2013

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
300142:CH CNY46.83 CNY -0.60

300142 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 300142.
View Industry Companies
 

Industry Analysis

300142

Industry Average

Valuation 300142 Industry Range
Price/Earnings 74.7x
Price/Sales 15.8x
Price/Book 2.9x
Price/Cash Flow 73.6x
TEV/Sales 11.3x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact WALVAX BIOTECHNOLOGY CO-A, please visit www.walvax.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.